Nugerontix Limited

Active06136155 Private limited company
Incorporated
5 March 2007 (19 years)
Previously known as
Flavosante Foods Limited (until 11 October 2012)
Flavosante Limited (until 6 June 2011)
This list may be incomplete. See all names on Companies House
Industry
Research and experimental development on biotechnology (72110)
Owned by
Roger Corder
Accounts type
Total exemption full
Region
West Midlands
Address
The Glades Festival Way
Festival Park
Stoke-On-Trent
ST1 5SQ

Filing status

Accounts due
30 June 2027
Last accounts
30 September 2025
Conf. stmt due
19 March 2027
Last conf. stmt
5 March 2026

Officers 2 active

Officer details are public data from the Companies House register.

Director · Appointed 5 March 2007
British
Born February 1957 (69)
Director · Appointed 5 March 2007
British
Born November 1955
Officer history (4 former)
4 March 2026
Resigned Peyer, James as Director
18 December 2023
Resigned Terstappen, Georg Christian as Director
2 November 2020
Appointed Peyer, James as Director
16 September 2020
Resigned Brunemeier, Philip Sebastian Aguiar as Director
8 July 2020
Appointed Brunemeier, Philip Sebastian Aguiar as Director
8 July 2020
Appointed Terstappen, Georg Christian as Director
2 January 2014
Resigned Bilyard, Kevin George as Secretary
5 March 2007
Appointed Bilyard, Kevin George as Director
5 March 2007
Appointed Corder, Roger, Professor as Director
5 March 2007
Appointed Bilyard, Kevin George as Secretary

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Roger Corder
Individual · Notified 30 June 2016
Owns 50–75% of shares
Holds 50–75% of voting rights
Right to appoint and remove directors
British
Born November 1956

Holdings 1

Companies where Nugerontix Limited is registered as a person with significant control

Owns 75–100% of shares
Active
Former controllers (3)
4 March 2026
Ceased Christian Berthold Angermayer — Owns 25–50% of shares
4 March 2026
Ceased James Peyer — Owns 25–50% of shares
29 November 2021
Ceased Cambrian Biopharma Inc — Owns 25–50% of shares

Financials

Balance sheet as at 30 September 2025 · total exemption full accounts

Cash
£40,675
Current Ratio
0.6x

Trend

Shareholder Funds
(£500k) £0 £500k £1.0M 2019 2020 2021 2022 2023 2024 2025 (£49,441) £333,682 £45,824 £938,119 £349,996 £36,559 (£13,244)
Balance sheet detail
2025202420232022202120202019
Fixed Assets£21,433£28,155£36,977£47,221£2,625£2,625£2,625
Current Assets£42,648£43,343£414,794£1,039,611£78,123£419,046£1,032
Debtors£1,973£12,520£21,467£26,294£3,350£11,186£94
Cash£40,675£30,823£393,327£1,013,317£74,773£407,860£938
Creditors (< 1 year)£77,325£34,939£101,775£148,713£34,924£87,989£53,098
Net Current Assets(£34,677)£8,404£313,019£890,898£43,199£331,057(£52,066)
Shareholder Funds(£13,244)£36,559£349,996£938,119£45,824£333,682(£49,441)

Filings

Recent filings only. See the full history on Companies House

Show all recent filings

Some other companies at this address

Other companies in this industry

By trade and location

New companies in Stoke-on-Trent →

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?